The fact that TAF6δ can act downstream of p53 to control gene expression, and that TAF6δ can dictate cell death versus life decisions of human cells, evoke the possibility that this newly defined pathway could be subject to deregulation in certain cancer cells. The gene discussed is TP53; the disease is cancer.